Publication | Open Access
Ponatinib suppresses the development of myeloid and lymphoid malignancies associated with FGFR1 abnormalities
109
Citations
22
References
2012
Year
Hematological MalignancyMalignant Blood DisorderFgfr1 AbnormalitiesPathologyFibroblast Growth FactorMedicineCell BiologyCancer ResearchTumor BiologyLymphoid MalignanciesMyeloid Neoplasia
| Year | Citations | |
|---|---|---|
Page 1
Page 1